Market Cap 6.32M
Revenue (ttm) 1.53M
Net Income (ttm) -93.44M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -6,107.19%
Debt to Equity Ratio 0.00
Volume 3,900
Avg Vol 54,408
Day's Range N/A - N/A
Shares Out 1.78M
Stochastic %K 9%
Beta -0.02
Analysts Hold
Price Target $11.50

Company Profile

Lyra Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of anti-inflammatory therapies for the treatment of patients with chronic rhinosinusitis. Its technology is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. The company's product candidates include LYR-210, an anti-inflammatory implantable drug matrix which is in Phase III clinical trial for the treatment of chronic rhi...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 393 4600
Address:
480 Arsenal Way, Watertown, United States
wolfhowll
wolfhowll Dec. 22 at 11:28 PM
$LYRA we're stuck or what?
0 · Reply
BioGem
BioGem Dec. 18 at 5:39 AM
$LYRA I read statements on other platforms that the exit of $INSM from the rhinosinusitis market leaves $LYRA as the main player in the space. Hopefully this brings more attention and capital to their product.
2 · Reply
topstockalerts
topstockalerts Dec. 15 at 3:57 PM
$LYRA waking up..
1 · Reply
BioGem
BioGem Dec. 12 at 9:38 PM
$LYRA I am taking a small stake here. The product works on real patients as shown in the second phase 3 trial, where criteria were more stringent. In the first phase 3 trial, patients were barely sick so not much difference could be shown. -The upcoming phase 3 trial will have the right inclusion criteria to show the stark difference and will go much faster and cheaper as they have the network, experience, and wrinkles all figured out. -They should easily raise 40-50M$ before year end, then the stock valuation and enterprise value will re-rate much higher. -Maybe Perceptive after their 30-day wash sale period is over, will reenter the stock at a much lower price in the offering. $XBI
1 · Reply
revuelto
revuelto Dec. 12 at 7:06 PM
$LYRA this price zone won’t last much longer 😀
1 · Reply
Day3
Day3 Dec. 11 at 11:33 AM
$LYRA They wrote to NASDAQ saying that they will be compliant with equity rule by 31st December 2025. They would have got extension until mid Feb 2026, but they didn't request it. Why wouldn't they request the extra 2.5 months extension? Possible explanations IMO: 1. Deep in discussions with new PIPE investors for$50M+ to fund new trial and NDA submission. 2. On the verge of restructuring/sub-letting their properties which would remove the$27M operating lease liability. 3. Both of the above Even if they miss the deadline, they can write to Nasdaq and request another extension to get one of the above done (given they didn't request the full allotted time originally). Nasdaq approved the initial extension based on 1 of the above scenarios so it won't be an issue to entend again, so long as company can prove progression. Perceptive selling out for tax loss purposes has provided an incredible entry point as any scenario above is positive for the stock.
0 · Reply
revuelto
revuelto Dec. 4 at 12:07 AM
$LYRA I would love to sell you at $41.9 😀
1 · Reply
revuelto
revuelto Dec. 2 at 5:46 PM
$LYRA expecting a straight sprb run here isn’t realistic but a 200% to 300% spike followed by an offering or a partnership….that’s more in line with what I see ✌️
1 · Reply
revuelto
revuelto Dec. 1 at 8:03 PM
$LYRA Was it a “get out before the fire sale” dynamic that perceptive followed? I’m questioning it given they had prime visibility into the boardroom…if they saw a lifeline they’d likely retain some skin in the game for upside…sanofi or any other partnership isn’t happening…who else objectively thinks the odds of liquidation are higher than any revival here? Having said that, I would love a 200%-300% runner here any day ✌️
0 · Reply
PaulLaurent
PaulLaurent Nov. 27 at 7:57 PM
🎯👀 Strong Watch Stocks 👀🎯 $PW $LYRA $GLBS $GP.X $LLYZ
0 · Reply
Latest News on LYRA
Why Is Lyra Therapeutics Stock Surging Over 400% On Monday?

Jun 2, 2025, 8:29 AM EDT - 7 months ago

Why Is Lyra Therapeutics Stock Surging Over 400% On Monday?


3 'Buy-Rated' Biotech Stocks Under $10

Apr 28, 2024, 4:39 AM EDT - 1 year ago

3 'Buy-Rated' Biotech Stocks Under $10

ADMA GERN


Lyra Therapeutics: Hold For Phase 3 Topline

Oct 10, 2023, 10:56 AM EDT - 2 years ago

Lyra Therapeutics: Hold For Phase 3 Topline


Lyra Therapeutics Announces $50.0 Million Private Placement

May 26, 2023, 7:57 AM EDT - 2 years ago

Lyra Therapeutics Announces $50.0 Million Private Placement


wolfhowll
wolfhowll Dec. 22 at 11:28 PM
$LYRA we're stuck or what?
0 · Reply
BioGem
BioGem Dec. 18 at 5:39 AM
$LYRA I read statements on other platforms that the exit of $INSM from the rhinosinusitis market leaves $LYRA as the main player in the space. Hopefully this brings more attention and capital to their product.
2 · Reply
topstockalerts
topstockalerts Dec. 15 at 3:57 PM
$LYRA waking up..
1 · Reply
BioGem
BioGem Dec. 12 at 9:38 PM
$LYRA I am taking a small stake here. The product works on real patients as shown in the second phase 3 trial, where criteria were more stringent. In the first phase 3 trial, patients were barely sick so not much difference could be shown. -The upcoming phase 3 trial will have the right inclusion criteria to show the stark difference and will go much faster and cheaper as they have the network, experience, and wrinkles all figured out. -They should easily raise 40-50M$ before year end, then the stock valuation and enterprise value will re-rate much higher. -Maybe Perceptive after their 30-day wash sale period is over, will reenter the stock at a much lower price in the offering. $XBI
1 · Reply
revuelto
revuelto Dec. 12 at 7:06 PM
$LYRA this price zone won’t last much longer 😀
1 · Reply
Day3
Day3 Dec. 11 at 11:33 AM
$LYRA They wrote to NASDAQ saying that they will be compliant with equity rule by 31st December 2025. They would have got extension until mid Feb 2026, but they didn't request it. Why wouldn't they request the extra 2.5 months extension? Possible explanations IMO: 1. Deep in discussions with new PIPE investors for$50M+ to fund new trial and NDA submission. 2. On the verge of restructuring/sub-letting their properties which would remove the$27M operating lease liability. 3. Both of the above Even if they miss the deadline, they can write to Nasdaq and request another extension to get one of the above done (given they didn't request the full allotted time originally). Nasdaq approved the initial extension based on 1 of the above scenarios so it won't be an issue to entend again, so long as company can prove progression. Perceptive selling out for tax loss purposes has provided an incredible entry point as any scenario above is positive for the stock.
0 · Reply
revuelto
revuelto Dec. 4 at 12:07 AM
$LYRA I would love to sell you at $41.9 😀
1 · Reply
revuelto
revuelto Dec. 2 at 5:46 PM
$LYRA expecting a straight sprb run here isn’t realistic but a 200% to 300% spike followed by an offering or a partnership….that’s more in line with what I see ✌️
1 · Reply
revuelto
revuelto Dec. 1 at 8:03 PM
$LYRA Was it a “get out before the fire sale” dynamic that perceptive followed? I’m questioning it given they had prime visibility into the boardroom…if they saw a lifeline they’d likely retain some skin in the game for upside…sanofi or any other partnership isn’t happening…who else objectively thinks the odds of liquidation are higher than any revival here? Having said that, I would love a 200%-300% runner here any day ✌️
0 · Reply
PaulLaurent
PaulLaurent Nov. 27 at 7:57 PM
🎯👀 Strong Watch Stocks 👀🎯 $PW $LYRA $GLBS $GP.X $LLYZ
0 · Reply
www_larval_com
www_larval_com Nov. 26 at 4:52 PM
$LYRA has shot 16% higher to 35% (~162Kv) a moment ago, 01/16 options, follow for more volatility.
0 · Reply
www_larval_com
www_larval_com Nov. 26 at 4:48 PM
$LYRA might ride this one if it comes back
0 · Reply
Akbigd
Akbigd Nov. 26 at 4:47 PM
$LYRA some weird Action with only 1.6 million shares outstanding
0 · Reply
DaBullRunner
DaBullRunner Nov. 26 at 4:36 PM
$LYRA lets go 🚨LNAI🚨another one that I am slowly adding off that sleeper news I’m even willing to put some of my TSLA COIN profits into LNAI👇💰💰💰
0 · Reply
Akbigd
Akbigd Nov. 26 at 3:59 PM
$LYRA Finally Perceptives is sold out, no more selling Pressure
0 · Reply
Stmkr
Stmkr Nov. 26 at 3:48 PM
$LYRA Yep. With selling pressure by Perceptives gone the rebound is starting
1 · Reply
tommy_john
tommy_john Nov. 26 at 3:47 PM
$LYRA @trader87 watch here
0 · Reply
topstockalerts
topstockalerts Nov. 26 at 1:57 PM
Pre Market Top Gainers $AMBR $MNDR $SPRC $LYRA $WOOF
0 · Reply
topstockalerts
topstockalerts Nov. 26 at 1:00 PM
Pre Market Top Gainers $MNDR $AMBR $LYRA $INHD $BODI
0 · Reply
revuelto
revuelto Nov. 25 at 10:49 PM
$LYRA perceptive completely sold out…surprised? Something’s off and the management is doing a shoddy job managing it .. https://www.sec.gov/Archives/edgar/data/1327273/000119312525297287/xslSCHEDULE_13D_X01/primary_doc.xml
0 · Reply
Stmkr
Stmkr Nov. 25 at 9:32 PM
$LYRA Finallt Perceptives sold out. Lets start rebounsing now. They need to announce a deal soon to avoid delisting
0 · Reply
Stmkr
Stmkr Nov. 25 at 8:31 PM
$LYRA I really need to stop buying here...
0 · Reply